Seminars

Expand your legal knowledge with our exclusive seminars.

Patent Seminar

Save the date: Next patent seminar on 10 April 2025

EQE Seminar

Two dates: 25/26 November 2024 and 14/15 December 2024

In 2024, our law firm is again offering a preparatory course for the C and D parts of the European Qualifying Examination (EQE exam). Two dates will be offered, with the courses on both dates having the same content, so attendance on one date is sufficient.

The course content is primarily focussed on suitable examination techniques and strategies for avoiding mistakes in order to be able to successfully tackle the C and D parts of the EQE examination with these skills. In our experience, well-prepared exam papers significantly increase the chances of success. We therefore want to provide participants with the necessary methodological knowledge in this course. In this respect, the course is to be understood as a supplement to the participants' own preparation of the legal foundations of the EPC. Instead, participants will learn how to convert their technical knowledge of the EPC into as many points as possible to pass the C and D parts of the EQE examination. The course takes place in Düsseldorf at our premises at Kaistrasse 16A and is free of charge. The course speakers are Dr Torsten Exner, Dipl.-Ing. Andreas Gröschel and Prof. Dr Aloys Hüttermann.

Registration is now open (please state your full name, the desired date and your employer) at eqe@mhpatent.de.

Rhineland Biopatent Forum

Next event on June 6, 2024

The “15th Rhineland Biopatent Forum” will take place June 6, 2024, in the premises of our firm in Düsseldorf.

Again, we were able to recruit a panel of high profile speakers. Dr. Bernd Hutter, former head of IP od Morphosys, will speak about patent portfolio management at the interface of start-ups, venture capital and exit strategies. In view of the 14 yrs he was at Morphosys, we can expect some valuable insights.

Then, we were impressed by the high output rate of spin-offs when we visited the Ghent University earlier this year, and had the chance to speak to Dr ir. Simon De Corte of the University’s TechTransfer office. Simon will explain to us the secrets of the success story of Ghent University’s unique innovation ecosystem.

And we could convince Dr. Oliver Sichelschmidt, Senior Director IP & Licensing at Qiagen, whom we know for more than a decade, to tell us about his approach on Patent Portfolio Efficiency. We are very interested to learn about techniques to establish a fact- and cost-driven decision process in the management of patent portfolios.

And, members of the firm will give presentation on other selected topics from the magical world of biopatents. One evergreen is the issue of epitope based antibody and TCR patents. Those who are regular attendees of the Rhineland Biopatent Forum will remember well a lively discussion between Gregory Cox of Eli Lilly and Maria Giuseppina Covone-van Hees of the EPO in 2012 already.

Further, there will be sufficient time for networking, or enjoying a refreshment on our terrific roof terrace facing the Düsseldorf Media Harbour.

If you plan to attend we would like to ask you to register early, simply by email to storz@mhpatent.de. We will then provide you with further documents as well as travel directions and hotel suggestions.

And, if you arrive the night before, join us for our traditional “Feierabendbier” reception! 

Register

  • + Program at Michalski • Hüttermann & Partner Patentanwälte mbB, Kaistrasse 16A, 40221 Duesseldorf

    5. June, 18.30: “Feierabendbier”
    (“After Work Reception”) for attendees who have arrived the evening before (address as above, we will then move to a bar nearby)

     

    08.30 - 9.00: Registration and Coffee
    09.00 - 09:45: The new T cell epitope target space - do we see a rebirth of epitope based claims ?
    Dr. Ulrich Storz,
    Patentanwälte Michalski ∙ Hüttermann & Partner mbB
    09.45 - 10:30: Portfolio management at the interface of start-ups, venture capital and exit strategies
    Dr. Bernd Hutter, Bernd Hutter Intellectual Property. Munich
    Chairperson: Dr Christoph Volpers, Patentanwälte Michalski ∙ Hüttermann & Partner mbB
    10.30 - 11.00: - Coffee Break -
    11.00 - 11.45: Patent Portfolio Efficiency
    Dr. Oliver Sichelschmidt, Senior Director IP & Licensing, Qiagen
    Chairperson: Dr. Ulrich Storz Patentanwälte Michalski ∙ Hüttermann & Partner mbB
    11.45 - 12.30: 80 spin-offs in 10 years – the unique Ghent University innovation ecosystem
    Dr. ir. Simon De Corte, Project Manager UGhent · TechTransfer (online Presentation)
    Chairperson: Pascal Poweleit, Patentanwälte Michalski ∙ Hüttermann & Partner mbB
    12.30 - 14.00: - Lunch Break -
    14.00 - 14.45: Learnings from patent prosecution in +30 countries – MHP’s unique treasure trove
    Dr. Jan Winkelnkemper,
    Patentanwälte Michalski ∙ Hüttermann & Partner mbB
    14.45 - 15.15: - Coffee Break -
    15.15 - 16.00: EU proposal on NGT plants, T2360/19 and G1/22 (CRISPR/Priority), Research exemption under the UPC agreement: the Biopatent world keeps spinning
    Menbers of the Firm,
    Patentanwälte Michalski ∙ Hüttermann & Partner mbB
    16.00: - Beverages -
This website is using cookies to provide a good browsing experience.

These include essential cookies that are necessary for the operation of the site, as well as others that are used only for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, not all functions of the website may be available.

This website is using cookies to provide a good browsing experience.

These include essential cookies that are necessary for the operation of the site, as well as others that are used only for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, not all functions of the website may be available.

Your cookie preferences have been saved.